quinic acid has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, N; Fang, J; Huang, L; Lin, Y; Liu, Q; Lyu, J; Pang, Y; Tan, G; Wang, J; Wang, X; Wang, Z; Xiang, Q | 1 |
| Guo, P; Liu, HT; Luan, H; Wang, S; Wu, CM; Zhang, XP | 1 |
2 other study(ies) available for quinic acid and Liver Neoplasms
| Article | Year |
|---|---|
Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Glucose Transporter Type 1; Glycolysis; Humans; Liver Neoplasms; Quinic Acid | 2022 |
[Pandanus tectorius derived caffeoylquinic acids inhibit lipid accumulation in HepG2 hepatoma cells through regulation of gene expression involved in lipid metabolism].
Topics: Carcinoma, Hepatocellular; China; Cholesterol; Gene Expression Regulation; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Oleic Acid; Pandanaceae; Quinic Acid; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2015 |